Terns Pharmaceuticals Soars: A New Dawn for Tough-to-Treat Leukemia Patients?
ASH 2025: Glimmers of Hope and Big Strides in Blood Disorders
A Glimmer of Hope: Syndax's Novel AML Drug Shines Bright at ASH Meeting